Articles dans des revues avec comité de lecture (90)
  1. 1. Akuze, J., Ngatia, B., Amare, S. Y., Wanduru, P., Otieno, G. P., Kananura, R. R., Kirakoya, F., Amouzou, A., Estifanos, A. S., & Ohuma, E. (2024). Unlocking the transformative potential of data science in improving maternal, newborn and child health in Africa: a scoping review protocol. BMJ open, 14(12), e091883. doi:10.1136/bmjopen-2024-091883
  2. 2. Ilboudo, D., Sombié, I., Koffi, A., Asiki, G., Yaméogo, T. M., & Kirakoya, F. (2024). Temporal trends analysis of emergency obstetric and newborn care availability and readiness index of healthcare facilities in Burkina Faso. BMC health services research, 24(1). doi:10.1186/s12913-024-11818-y
  3. 3. Larcin, L., Ngwasiri, C., Neven, A., Damase‐Michel, C., & Kirakoya, F. (2024). Real‐World Assessment of Psychotropic and Antiepileptic Drug Use During Pregnancy in Belgium: Trends, Predictors, and Comparative Risk of Congenital Anomalies (2010–2016). Pharmacoepidemiology and drug safety, 33(10). doi:10.1002/pds.70021
  4. 4. Ukwishaka, J., Mela, C. F., Aseneh, J. B. N., Ettaj, M., Ilboudo, D., Danwang, C., Samadoulougou, S., & Kirakoya, F. (2024). Seroprevalence of SARS-CoV-2 antibodies among healthy blood donors: a systematic review and meta-analysis. BMC public health, 24(1), 2925. doi:10.1186/s12889-024-20364-5
  5. 5. Crouzier, C., Van Schaeybroeck, B., Duchêne, F., Dejardin-Duchene, M., Hamdi, R., Kirakoya, F., & Demoury, C. (2024). The impact of climate and demographic changes on future mortality in Brussels, Belgium. Public health, 236, 261-267. doi:10.1016/j.puhe.2024.07.028
  6. 6. Michiels, S., Tricas-Sauras, S., Salaroli, A., Bron, D., Lewalle, P., Vanschoenbeek, K., Poirel, H. A., & Kirakoya, F. (2024). Imatinib Adherence and Persistence in Patients with Chronic Myeloid Leukemia in Belgium: Evidence from Real-World Data. Patient Preference and Adherence, Volume 18, 1991-2006. doi:10.2147/PPA.S472478
  7. 7. Ouoba, K. J., Haro-Lankoandé, S., Nacoulma, A. P., Merle, C. S. C., Hennig, B. J., Fofana, S., Kaboré, L., Ouédraogo, E., Sawadogo, R., Samadoulougou, S., & Kirakoya, F. (2024). Evaluation of the Med Safety mobile app for reporting adverse events in Burkina Faso. Drugs & therapy perspectives, 40(8), 330-339. doi:10.1007/s40267-024-01078-5
  8. 8. Ouoba, K. J., Haro-Lankoandé, S., Nacoulma, A., Merle, C. S. C., Hennig, B. J., Fofana, S., Kaboré, L., Ouédraogo, E., Sawadogo, R., Samadoulougou, S., & Kirakoya, F. (2024). Evaluation of the Med Safety mobile app for reporting adverse events in Burkina Faso. Drugs & therapy perspectives, 40(8), 330-339. doi:10.1007/s40267-024-01078-5
  9. 9. Ilboudo, D., Ngwasiri, C., Savoye, I., Sommet, A., Beckhoven, D. V., Yombi, J., & Kirakoya, F. (2024). Brief communication: temporal trends of chronic diseases medications prescriptions among HIV-infected patients in Belgium: a 4-year population-based study using pharmacy claims data. AIDS Research and Therapy, 21(1), 48. doi:10.1186/s12981-024-00634-3
  10. 10. Ilboudo, D., Mbouche, P., Sommet, A., Van Wilder, P., & Kirakoya, F. (2024). Non-adherence and non-persistence with antiretroviral treatment in Belgium: A real-world evaluation using a pharmacy database, 2018-2021. Pharmacoepidemiology and drug safety, 33(5), e5804. doi:10.1002/pds.5804
  11. 11. Tassembedo, S., Traore, I. T., Ouedraogo, A.-S., Meda, N., Van de Perre, P., Nagot, N., & Kirakoya, F. (2024). Context-specific estimates of vertical transmission. The Lancet HIV. doi:10.1016/S2352-3018(24)00095-X
  12. 12. Sawadogo, R., Ouoba, K. J., Ilboudo, D., Tchoumbi, E., Lankoandé-Haro, S., Fofana, S., Sombié, I., Samadoulougou, S., & Kirakoya, F. (2024). Manifestations post-vaccinales indésirables rapportées avec les vaccins anti-COVID-19 au Burkina Faso: analyse des notifications spontanées. Santé publique, 35(6), 149-159.
    13. << Précédent 1 2 3 4 5 6 7 8 9 10 Suivant >>